RxDoctor Payments Data

Sandra Mazur, NP

Family Medicine · Bolingbrook, ILNPI 1588651509

Payments from drug & device makers

$1,803in general payments, 2019–2025

Across 68 payments — averaging $26.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$461
  • Novo Nordisk$278
  • AstraZeneca$274
  • AbbVie$251
  • Lilly USA, LLC$147
  • Axsome Therapeutics, Inc.$112
  • plus $280 from 10 others

What the payments were for

  • Food & beverage$1,803100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,803 in reported general payments places this provider in the 80th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$18,903
Medicare patients
89
Services billed
231

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide15$14,563
Rosuvastatin Calcium68$895
Levothyroxine Sodium83$774
Atorvastatin Calcium72$593
ValacyclovirValacyclovir Hcl11$451
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide22$303
Irbesartan-HydrochlorothiazideIrbesartan/Hydrochlorothiazide14$287
Albuterol Sulfate HfaAlbuterol Sulfate11$273
Amlodipine Besylate73$273
Telmisartan14$257
Pantoprazole Sodium23$257
Alendronate Sodium13$236
Diclofenac Sodium15$223
Spironolactone16$201
Metoprolol Succinate16$195

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$278$14,56315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Bolingbrook

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →